Your browser doesn't support javascript.
loading
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.
Abraham, Roshini S; Marshall, Joanna M; Kuehn, Hye Sun; Rueda, Cesar M; Gibbs, Amber; Guider, Will; Stewart, Claire; Rosenzweig, Sergio D; Wang, Huanyu; Jean, Sophonie; Peeples, Mark; King, Tiffany; Hunt, W Garrett; Honegger, Jonathan R; Ramilo, Octavio; Mustillo, Peter J; Mejias, Asuncion; Ardura, Monica I; Shimamura, Masako.
Affiliation
  • Abraham RS; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: Roshini.Abraham@nationwidechildrens.org.
  • Marshall JM; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • Kuehn HS; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Md.
  • Rueda CM; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • Gibbs A; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • Guider W; Division of Critical Care Medicine, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio.
  • Stewart C; Division of Critical Care Medicine, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio.
  • Rosenzweig SD; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Md.
  • Wang H; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • Jean S; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • Peeples M; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio.
  • King T; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio.
  • Hunt WG; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Division of Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio.
  • Honegger JR; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio; Division of Infectious Diseases, Nationwide Children's
  • Ramilo O; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio; Division of Infectious Diseases, Nationwide Children's
  • Mustillo PJ; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio.
  • Mejias A; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio; Division of Infectious Diseases, Nationwide Children's
  • Ardura MI; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Division of Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio.
  • Shimamura M; Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio; Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio; Division of Infectious Diseases, Nationwide Children's
J Allergy Clin Immunol ; 147(2): 532-544.e1, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33007327
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: NF-kappa B p52 Subunit / SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Humans / Male Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: NF-kappa B p52 Subunit / SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Humans / Male Language: En Year: 2021 Type: Article